Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Abbie Kelley

Nurse Practitioner, Psychiatric/Mental Health Cedar Rapids, IA Nurse Practitioner

NPI 1114510575 CMS profile 10913981

3900 Fountains Blvd Ne Ste 203, Cedar Rapids, IA 52411

Open in the dashboard

General payments

$6,533

439 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Abbie Kelley of Cedar Rapids, IA is reported in the CMS Open Payments database as having received $6,533 across 439 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,095 117
2024 General $1,427 102
2023 General $1,032 82
2022 General $1,293 87
2021 General $687 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Abbie Kelley
  • Nurse Practitioner, Psychiatric/Mental Health median
  • Middle half of Nurse Practitioner, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Abbie Kelley were reported at $2,095. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.

Show as a table
Year Abbie Kelley Nurse Practitioner, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $687 $166 $54–$482 $132
2022 $1,293 $195 $66–$559 $149
2023 $1,032 $233 $82–$673 $160
2024 $1,427 $236 $84–$688 $164
2025 $2,095 $258 $93–$764 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,596 129 payments
  2. ITI, Inc. $1,204 77 payments
  3. Otsuka America Pharmaceutical, Inc. $613 37 payments
  4. Neurocrine Biosciences, Inc. $464 53 payments
  5. Teva Pharmaceuticals USA, Inc. $407 14 payments
  6. Corium, Inc. $287 24 payments
  7. Lundbeck LLC $268 13 payments
  8. Vanda Pharmaceuticals Inc. $237 11 payments
  9. Alkermes, Inc. $229 12 payments
  10. Ironshore Pharmaceuticals Inc. $206 12 payments
  11. Other $1,021 57 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,383 436 payments
  2. Education $150 3 payments
Products named General payments · program years 2021–2025
  1. VRAYLAR Neuroscience $1,191 106 payments
  2. CAPLYTA Psychiatry $951 62 payments
  3. REXULTI Psychiatry $499 30 payments
  4. INGREZZA $464 53 payments
  5. VRAYLAR Neuroscience $405 23 payments
  6. Azstarys $287 24 payments
  7. CAPLYTA Psychiatry $253 15 payments
  8. REXULTI Psychiatry $244 11 payments
  9. FANAPT $237 11 payments
  10. Austedo XR $228 7 payments
  11. Other $2,699 149 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

439 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Psychiatric/Mental Health in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record